All
  • All
  • Product Management
  • News
  • Introduction
  • Enterprise outlets
  • FAQ
  • Enterprise Video
  • Enterprise Atlas
Search

Corporate News

Industry News

Learning Center

News

News Center

2024.12.23

Chuangyuan Biotechnology & Haihe Dairy | Joint Construction of Party Branches Promotes Development, Party Building Collaborates to Write a New Chapter

In December 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. and Haihe Dairy jointly held a series of themed activities titled "Party Building Mutual Visits and Learning" to further promote the deep integration of both parties' party building work and business development. During the event, both sides will conduct company visits and on-site discussions. Recently, Haihe Dairy made an initial visit and, after gaining a deep understanding of Chuangyuan Biotech's products, expressed high recognition and close attention, laying a solid foundation for future cooperation. Subsequently, both parties engaged in detailed communication on the core topics of "exchange of party building experiences and sharing of business resources," discussing standardized construction of party branches, distinctive party building measures, and the promotion of party-business integration. They also conducted in-depth exchanges on aspects such as corporate cooperation, product intercommunication, and information sharing, jointly exploring new paths for the development of the health industry under the guidance of party building, providing more possibilities for further establishing a "symbiotic, mutually promoting, and win-win" cooperative relationship. Both parties hope to achieve industrial resonance through party building leadership and contribute to the development of the health industry in the Binhai New Area.

Chuangyuan Biotechnology & Haihe Dairy | Joint Construction of Party Branches Promotes Development, Party Building Collaborates to Write a New Chapter

2024.12.17

Strength crowned, Chuangyuan Biotechnology won two Science and Technology Awards from the China Food Industry Association.

On December 16, 2024, the 22nd China Food Safety Conference and the 2024 National Food Industry Science and Technology Progress Conference, themed "Implementing Food Safety Strategy to Support the Construction of a Healthy China," was grandly held in Beijing. During the conference, the award ceremony for the 2024 National Food Industry Science and Technology Progress Conference was also held. Tianjin Chuangyuan Biotechnology Co., Ltd. won the second prize for scientific and technological progress in the "2023 China Food Industry Association Science and Technology Award" for two projects: "Key Technology Breakthrough and Industrial Application of New Postbiotics Segmented Solid-State Fermentation" and "Development and Application of Key Technologies and Equipment for Plant Polysaccharide Efficacy Verification and Extraction."

Strength crowned, Chuangyuan Biotechnology won two Science and Technology Awards from the China Food Industry Association.

2024.12.13

Chuangyuan Biotech's lactic acid bacteria IOB701 post-fermentation probiotic powder has been granted a national invention patent.

On December 13, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate from the National Intellectual Property Administration for its independently developed and filed method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder (Patent No.: ZL 202411354886.X). This invention provides a method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder, which relates to the field of microbiology. The Lactobacillus plantarum IOB701 was preserved on July 10, 2018, at the General Microbial Culture Collection Center of the China Microbial Strain Preservation Management Committee, abbreviated as CGMCC, with the preservation address at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number CGMCC No. 16077. Using grains or legumes treated with low oxygen stress as the fermentation substrate, the Lactobacillus plantarum IOB701 fermentation resulted in postbiotics powder, which, according to animal experiments, has been shown to improve chronic unpredictable mild stress-induced depressive-like behavior in mice.

Chuangyuan Biotech's lactic acid bacteria IOB701 post-fermentation probiotic powder has been granted a national invention patent.

2024.12.02

Chuangyuan Biotechnology and Tianjin Vocational College of Bioengineering held a signing ceremony to jointly establish the 'Bioengineering Chuangyuan Biotechnology Industry College'.

On November 29, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. held a signing ceremony with Tianjin Bioengineering Vocational Technical College to sign a strategic cooperation framework agreement for the industry college. Zhang Lijun, the president of Tianjin Bioengineering Vocational Technical College, Kong Dongjun, the head of the school-enterprise cooperation department, Zhang Kejun, the secretary and director of the biotechnology department, Bi Ye, the deputy secretary of the biotechnology department, Cao Jia, the leader of the food inspection and testing technology program, and Zhao Xuelan, a key teacher in the food inspection and testing technology program, along with a group of 66 teachers and students, visited Chuangyuan Biotechnology and attended the signing ceremony. Shi Yali, the executive vice president of Chuangyuan Biotechnology, and vice president Xing Jiqiang, along with relevant department heads, received them.

Chuangyuan Biotechnology and Tianjin Vocational College of Bioengineering held a signing ceremony to jointly establish the 'Bioengineering Chuangyuan Biotechnology Industry College'.

2024.12.02

Chuangyuan Biotechnology has been granted a national invention patent for its research on proprietary strains.

On November 29, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate from the National Intellectual Property Administration for its independently developed and filed patent titled "Rhamnosus Lactobacillus for Improving Lipid Metabolism and Its Application" (Patent No.: ZL 202411187281.6). This invention provides a Rhamnosus Lactobacillus that improves lipid metabolism and its applications, relating to the field of microbiology. The Rhamnosus Lactobacillus is named IOB820, classified as Lacticaseibacillus rhamnosus, and was preserved on April 3, 2019, at the General Microbial Culture Collection Center of the China Microbial Strain Preservation Management Committee, abbreviated as CGMCC, with the preservation number CGMCC No.17522. According to animal experiments, this strain effectively upregulates the mRNA expression of carnitine palmitoyltransferase 1, thereby promoting the β-oxidation of fatty acids and regulating lipid metabolism. It can also alleviate inflammation symptoms in mice, reducing the levels of TNF-α, IL-1β, and IL-6 in high-fat mice, thus inhibiting chronic low-grade inflammation associated with lipid metabolism disorders and improving the imbalance of gut microbiota caused by lipid metabolism disorders.

Chuangyuan Biotechnology has been granted a national invention patent for its research on proprietary strains.

2024.11.21

Exhibition Highlights | Chuangyuan Bio's 2024 NHNE Special Presentation, Innovative Postbiotics Boosting the Development of the Health Industry

Chuangyuan Bio is showcasing probiotics, postbiotics, small molecule peptides, and its own brand series products under IOB®, as well as the new consumer product series 【Postbiotics+】. The exhibits include mainstream dosage forms in the market such as powders, liquids, tablets, and gummy candies. The focus is on recommending the IOBPRO® series of postbiotic raw materials, aiming to provide customers with one-stop product solutions and offer consumers innovative and selected nutritional intervention products. At the same time, it provides blue ocean materials for clients in the food and health industries, helping them break through in the red ocean.

Exhibition Highlights | Chuangyuan Bio's 2024 NHNE Special Presentation, Innovative Postbiotics Boosting the Development of the Health Industry
< 1234...39 >

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoOrigin
InnoOrigin

Copyright 2024 © Tianjin InnoOrigin Biological Biotechnology Co., Ltd.

Picture Name

Jin Gong Wang An Bei No. 12019202000539

Powered by www.300.cn     SEO

Business License